Lawsuit Alleges Kyndryl Manipulated Free Cash Flow Metrics

What happened

Kuehn Law announced an investigation into Kyndryl Holdings, alleging that management manipulated free cash flow by systematically delaying vendor payments, and that reported cash flow metrics were not indicative of sustainable earnings quality. The suit also claims that Kyndryl's internal controls and accounting methodologies were materially inadequate. This news casts doubt on the reliability of Kyndryl's free cash flow generation, which is a central pillar of the company's turnaround narrative and its current valuation at ~11x EPS and ~5.5x EV/EBITDA. While Kyndryl has guided to ~$550M in FY26 free cash flow, the lawsuit suggests that past reported figures may have been artificially inflated, potentially threatening future cash conversion and management's credibility. The stock has already fallen ~30% over the past year amid skepticism about revenue growth, and this legal overhang adds another layer of risk.

Implication

If the allegations prove meritless, the current low valuation may offer an entry point, but investors should wait for more clarity on the substance of the claims and any impact on reported financials before adding to positions. The thesis relies on FCF growth; until the cloud lifts, a cautious stance is warranted.

Thesis delta

The shareholder lawsuit alleging manipulation of free cash flow through vendor payment timing introduces significant uncertainty about the quality and sustainability of Kyndryl's cash generation, which was a key support for the bullish case. Previously, the DeepValue report highlighted record signings and margin expansion as indicators of a turnaround; now, the credibility of reported FCF is challenged, potentially impairing the margin of safety. If the allegations are upheld, the FY26 FCF guidance of ~$550M could prove unreliable, undermining the investment thesis.